Voice your opinion on congressional bill HR2376-116 and let lawmakers know your stance with UnPac!

Main Subject: Commerce

Prescription Pricing for the People Act of 2019

This bill directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain.

HR19-116, S1227-116, HR2296-116,

House committee actions Actions

Committee
May. 21 2019	Subcommittee Hearings Held.
Apr. 30 2019	Referred to the Subcommittee on Consumer Protection and Commerce. Ordered to be Reported by Voice Vote. Committee Consideration and Mark-up Session Held. Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Apr. 29
2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Apr. 29 2019	Introduced in House Introduced in House

House bill HR2376-116

Prescription Pricing for the People Act of 2019

Promote the cause!

Or use this QR code